View Latest Issue
The US Food and Drug Administration approved the use of apremilast (Otezla), a phosphodiesterase-4 inhibitor, on March 21, 2014, for the treatment of adults with active psoriatic arthritis.
Many nurse practitioners (NPs) and physician assistants (PAs) working in rheumatology clinics appear ready and willing to diagnose and treat rheumatoid arthritis (RA), according to a recently published survey. The results may pinpoint a key to preventing the projected shortfall in rheumatologists in the near future, the researchers suggest.
Contemporary guidelines for the management of osteoarthritis (OA) from different stakeholder organizations are generally consistent, according to a systematic review of the literature undertaken as an initiative of the Chronic Osteoarthritis Management Initiative Work Group.
To simplify the process of identifying patients who have osteoporosis or are at elevated risk of the common condition, a company has created the Osteoporosis Advisor.
As healthcare reform continues to unfold, an increasing amount of pressure is being placed on payers, providers, and patients to address the rising cost of care. Greater attention is being paid to patients with inflammatory arthritis and other autoimmune conditions treated with chronic biologic therapies.
Close to 17% of patients with rheumatoid arthritis (RA) may have depression, according to the results of a systematic review and meta-analysis.
New recommendations for juvenile idiopathic arthritis (JIA) were published in 2013, updating the previous set of recommendations from 2011.
San Diego, CA—The concept of “treat-to-target” (T2T) is key to optimizing disease control and outcomes in patients with rheumatoid arthritis (RA).
Implementation of the Patient Protection and Affordable Care Act has led to an increasing focus on improving quality of care and patient outcomes.
Patients with rheumatoid arthritis (RA) receive different care depending on where they live, and this has an impact on their outcomes, according to a study presented at the 2013 American College of Rheumatology (ACR) Meeting. Patients with RA who live in the Mountain region are treated according to ACR guidelines more often than patients who live in other regions of the United States.
Page 2 of 3
Results 11 - 20 of 28
  • Rheumatology Practice Management
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology